Olema Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	68.54	23.7	13.81	338.55	0.07	3.15
Short-Term Investments	193.27	180.72	273.44	0	0	0
Cash & Cash Equivalents	261.81	204.42	287.25	338.55	0.07	3.15
Cash Growth	28.07%	-28.84%	-15.15%	497766.18%	-97.84%	-
Other Current Assets	4.71	4.48	3.44	3.59	0.04	0.09
Total Current Assets	266.51	208.9	290.69	342.14	0.1	3.24
Property, Plant & Equipment	2.29	2.5	4.72	0.08	0.03	0.03
Other Long-Term Assets	8.14	4.25	0.54	0.51	0	0
Total Long-Term Assets	10.43	6.75	5.26	0.59	0.03	0.03
Total Assets	276.95	215.65	295.95	342.72	0.13	3.27
Accounts Payable	2.7	0.37	0.02	0.72	0.94	0.12
Current Debt	0.99	1.02	0.93	0	0	0
Other Current Liabilities	17.94	15.16	8.07	3.87	0.44	0.09
Total Current Liabilities	21.62	16.55	9.02	4.59	1.38	0.2
Long-Term Debt	1.43	1.55	2.36	0	0	0
Total Long-Term Liabilities	1.43	1.55	2.36	0	0	0
Total Liabilities	23.05	18.1	11.38	4.59	1.38	0.2
Total Debt	2.42	2.57	3.29	0	0	0
Debt Growth	-5.77%	-22.01%	-	-	-	-
Retained Earnings	-305.63	-208.98	-104.19	-33.09	-10.76	-
Comprehensive Income	0.35	-1.81	-0.15	0	0	0
Shareholders' Equity	253.9	197.55	284.57	338.14	-10.59	3.07
Net Cash / Debt	259.39	201.86	283.96	338.55	0.07	3.15
Net Cash / Debt Growth	28.50%	-28.91%	-16.12%	497766.18%	-97.84%	-
Net Cash Per Share	5.73	5.05	7.18	48.22	0.03	1.25
Working Capital	244.89	192.35	281.67	337.55	-1.28	3.04
Book Value Per Share	5.61	4.94	7.20	48.16	-4.08	1.22

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).